Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10039762 Inhibitors of influenza viruses replication

Patent 10039762 was granted and assigned to Vertex Pharmaceuticals on August, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 8 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 8 Dec, 2023
Edits made to:
Article (+361 characters)
Article

Patent abstract

Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I):

Edits on 1 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 1 Oct, 2023
Edits made to:
Infobox (+27 properties)
Infobox
Patent Inventor Names
Ann Dak-Yee Kwong0
Brian Ledford0
Chao Lin0
Dylan H. Jacobs0
Emanuele Perola0
Francesco G. Salituro0
Francois Maltais0
Hongbo Deng0
Huai Gao0
Ioana Davies0
John J. Court0
John P. Duffy0
Joseph M. Kennedy0
Luc J. Farmer0
M. Woods Wannamaker0
Mark W. Ledeboer0
Michael P. Clark0
Min Jiang0
Paul S. Charifson0
Randal Byrn0
Randy S. Bethiel0
Steven Jones0
Tiansheng Wang0
Upul K. Bandarage0
Ursula A. Germann0
Wenxin Gu0
Yi Zhou0
Edits on 28 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Edits on 7 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 7 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Vertex Pharmaceuticals
Vertex Pharmaceuticals
0
Current Assignee
Vertex Pharmaceuticals
Vertex Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
100397620
Date of Patent
August 7, 2018
0
Patent Application Number
157181860
Date Filed
September 28, 2017
0
Patent Citations Received
‌
US Patent 10273233 Inhibitors of influenza viruses replication
0
‌
US Patent 10533004 Methods of preparing inhibitors of influenza viruses replication
0
‌
US Patent 10640501 Methods of preparing inhibitors of influenza viruses replication
0
‌
US Patent 10874673 Inhibitors of influenza viruses replication
0
‌
US Patent 10875855 Inhibitors of influenza viruses replication
0
‌
US Patent 10927118 Inhibitors of influenza virus replication and uses thereof
0
‌
US Patent 11345700 Methods of preparing inhibitors of influenza viruses replication
0
Patent Primary Examiner
‌
Shengjun Wang
0
Edits on 31 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 31 Mar, 2023
Edits on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Edits on 22 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Mar, 2023
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 24 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Edits on 22 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Edits on 1 Jun, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11345700 Methods of preparing inhibitors of influenza viruses replication
Edits on 10 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 10 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10927118 Inhibitors of influenza virus replication and uses thereof
Edits on 8 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 8 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10875855 Inhibitors of influenza viruses replication
"update inverses"
Golden AI profile picture
Golden AI
edited on 8 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10874673 Inhibitors of influenza viruses replication
Edits on 3 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10640501 Methods of preparing inhibitors of influenza viruses replication
Edits on 31 Jan, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 Jan, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10533004 Methods of preparing inhibitors of influenza viruses replication
Edits on 26 Jan, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 26 Jan, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10273233 Inhibitors of influenza viruses replication
Edits on 21 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 21 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10039762 Inhibitors of influenza viruses replication

Infobox
Is a
Patent
Patent
Patent applicant
Vertex Pharmaceuticals
Vertex Pharmaceuticals
Current assignee
Vertex Pharmaceuticals
Vertex Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10039762
Date of patent
August 7, 2018
Patent application number
15718186
Date Filed
September 28, 2017
Patent primary examiner
‌
Shengjun Wang

Find more entities like US Patent 10039762 Inhibitors of influenza viruses replication

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.